CDC Reports on 2001-03 Pertussis surveillance data. January 3, 2006

Rating

Average:

0

Your rating: None

FDA Approves First U.S. Vaccine for Humans Against the Avian Influenza Virus H5N1

The vaccine could be used in the event the current H5N1 avian virus were to develop the capability to efficiently spread from human to human, resulting in the rapid spread of the disease across the globe. Should such an influenza pandemic emerge, the vaccine may provide early limited protection in the months before a vaccine tailored to the pandemic strain of the virus could be developed and produced

Rating

Average:

0

Your rating: None

National Influenza Vaccine Newsletter

To help raise awareness of influenza vaccination recommendations and the importance of continuing vaccination efforts throughout November and beyond, the United States Department of Health and Human Services (HHS), the Centers for Disease Control and Prevention (CDC), the National Influenza Vaccine Summit, partners and stakeholders will be announcing a National Influenza Vaccination Week (NIVW) from Monday, November 27th through Sunday, December 3rd, 2006.

Rating

This table for healthcare providers and planners provides information related to spacing between the two doses of 2009 H1N1 vaccine for children 6 months through 9 years of age and for administration of 2009 H1N1 vaccine with seasonal influenza and other vaccines.